115 related articles for article (PubMed ID: 26348213)
1. Clinical and pathological parameters prognostic for increased risk of recurrence after postoperative radiotherapy for temporal bone carcinoma.
Marioni G; Zanoletti E; Giacomelli L; Braggio L; Martini A; Mazzoni A
Head Neck; 2016 Jun; 38(6):894-8. PubMed ID: 26348213
[TBL] [Abstract][Full Text] [Related]
2. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
[TBL] [Abstract][Full Text] [Related]
3. Temporal bone squamous cell carcinoma: analyzing prognosis with univariate and multivariate models.
Zanoletti E; Marioni G; Stritoni P; Lionello M; Giacomelli L; Martini A; Mazzoni A
Laryngoscope; 2014 May; 124(5):1192-8. PubMed ID: 24108656
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma of the temporal bone: outcomes of radical surgery and postoperative radiotherapy.
Leong SC; Youssef A; Lesser TH
Laryngoscope; 2013 Oct; 123(10):2442-8. PubMed ID: 23553471
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic role of pSTAT3 expression in temporal bone squamous cell carcinoma.
Marioni G; Nucci R; Marino F; Cappellesso R; Pillon M; Zanoletti E; Giacomelli L; Franchella S; Billo P; Pareschi R; Martini A
Otol Neurotol; 2013 Oct; 34(8):1476-82. PubMed ID: 24005169
[TBL] [Abstract][Full Text] [Related]
6. A panel of biomarkers for predicting response to postoperative RT for laryngeal cancer?
Marioni G; Ottaviano G; Lionello M; Fasanaro E; Staffieri C; Giacomelli L; Gattazzo S; Staffieri A; Blandamura S
Am J Otolaryngol; 2014; 35(6):771-8. PubMed ID: 25064017
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for treating temporal bone carcinoma based on long-term outcomes.
Bacciu A; Clemente IA; Piccirillo E; Ferrari S; Sanna M
Otol Neurotol; 2013 Jul; 34(5):898-907. PubMed ID: 23507994
[TBL] [Abstract][Full Text] [Related]
8. Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105.
Marioni G; Nucci R; Marino F; Giacomelli L; Rugge M; Pareschi R; Martini A
Otol Neurotol; 2012 Jul; 33(5):843-8. PubMed ID: 22643443
[TBL] [Abstract][Full Text] [Related]
9. Inverted papilloma involving the temporal bone and its association with squamous cell carcinoma: critical analysis of the literature.
Gaio E; Marioni G; Blandamura S; Staffieri A
Expert Rev Anticancer Ther; 2005 Apr; 5(2):391-7. PubMed ID: 15877533
[TBL] [Abstract][Full Text] [Related]
10. Neck dissection for squamous cell carcinoma of the head and neck.
Santa Maria PL; Sader C; Preston NJ; Fisher PH
Otolaryngol Head Neck Surg; 2007 Apr; 136(4 Suppl):S41-5. PubMed ID: 17398340
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma involving the temporal bone: lateral temporal bone resection as primary intervention.
Lassig AA; Spector ME; Soliman S; El-Kashlan HK
Otol Neurotol; 2013 Jan; 34(1):141-50. PubMed ID: 23202152
[TBL] [Abstract][Full Text] [Related]
12. Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx.
Iizuka Y; Yoshimura M; Inokuchi H; Matsuo Y; Nakamura A; Mizowaki T; Hirano S; Kitamura M; Tateya I; Hiraoka M
Acta Otolaryngol; 2015 Jan; 135(1):96-102. PubMed ID: 25351439
[TBL] [Abstract][Full Text] [Related]
13. Expression of the tumour-suppressor maspin in temporal bone carcinoma.
Marioni G; Zanoletti E; Stritoni P; Lionello M; Giacomelli L; Gianatti A; Cattaneo L; Blandamura S; Mazzoni A; Martini A
Histopathology; 2013 Aug; 63(2):242-9. PubMed ID: 23730906
[TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma of the temporal bone.
Gidley PW; Roberts DB; Sturgis EM
Laryngoscope; 2010 Jun; 120(6):1144-51. PubMed ID: 20513031
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
[TBL] [Abstract][Full Text] [Related]
16. Cortactin and phosphorylated cortactin tyr
Marioni G; Zanoletti E; Mazzoni A; Gianatti A; Valentini E; Girasoli L; Guariento M; Giacomelli L; Martini A; Blandamura S
Am J Otolaryngol; 2017; 38(2):208-212. PubMed ID: 28131549
[TBL] [Abstract][Full Text] [Related]
17. Relaxin-2 expression in temporal bone carcinoma.
Marioni G; Zanoletti E; Lovato A; Franchella S; Giacomelli L; Gianatti A; Mazzoni A; Blandamura S; Martini A
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3225-32. PubMed ID: 25388992
[TBL] [Abstract][Full Text] [Related]
18. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates.
Fan KH; Wang HM; Kang CJ; Lee LY; Huang SF; Lin CY; Chen EY; Chen IH; Liao CT; Chang JT
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1024-9. PubMed ID: 20610038
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for squamous cell carcinoma of the temporal bone: extensive bone involvement or extensive soft tissue involvement?
Ito M; Hatano M; Yoshizaki T
Acta Otolaryngol; 2009 Nov; 129(11):1313-9. PubMed ID: 19863330
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of patients with temporal bone squamous cell carcinoma with different invasion patterns.
Xie B; Zhang T; Dai C
Head Neck; 2015 Feb; 37(2):188-96. PubMed ID: 24347537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
